Skip to main navigation

Corporate
Healthcare Professionals
Patients

Health Policy Resources
Contact Us

About Axonics
Investor Relations
Newsroom and Events
Careers
Contact Us

News Releases

News Releases

Year

Nov 05, 2019

Axonics® Responds to Patent Action by Medtronic

Nov 01, 2019

Axonics® Announces First Commercial U.S. Patient Implanted with its Sacral Neuromodulation System

Oct 15, 2019

Axonics® Provides Update on U.S. Launch Activities

Oct 07, 2019

Axonics® Broadens EU Commercial Footprint with Recommendation for Reimbursement in France and Supply Contract in Norway

Oct 03, 2019

Axonics® Provides Full One-Year Results from ARTISAN-SNM Pivotal Study at AUGS/IUGA Joint Scientific Meeting

Oct 02, 2019

Axonics® Announces Exclusive Agreement to Supply Sacral Neuromodulation Systems to Leading Urology Practice Group

Sep 24, 2019

Axonics® to Exhibit its Sacral Neuromodulation System at the AUGS/IUGA Joint Scientific Meeting on September 24 – 28 in Nashville

Sep 09, 2019

Axonics® Announces U.S. Food & Drug Administration Approval for its Sacral Neuromodulation System

Aug 27, 2019

Axonics® to Present at Upcoming Investor Conferences

Aug 05, 2019

Axonics® Announces Second Quarter 2019 Financial Results and Operational Update

Pagination

First page
Previous page
Page 1
Current page 2
Page 3
Page 4
Next page
Last page

Print Page Email Page Email Alerts RSS Feeds

Questions?

We are here to help answer any questions you may have about the Axonics System and Therapy.

CONTACT US

Corporate Healthcare Professionals Patients

About Axonics Investor Relations Newsroom and Events Careers Contact Us

Contact Us

©2019 Axonics Modulation Technologies, Inc. Axonics^® and Axonics Modulation Technologies^® are trademarks of Axonics Modulation Technologies, Inc., registered or pending registration in the U.S. and other countries.
Privacy Policy | Terms of Use | Important Safety Information | Sitemap